Breakdown | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 13.95B | 13.44B | 10.78B | 4.80B | 1.64B |
Gross Profit | 2.65B | 3.88B | 3.04B | 791.10M | -66.90M |
EBITDA | 3.07B | 3.06B | 2.28B | 325.30M | -467.90M |
Net Income | 1.61B | 1.92B | 1.31B | -240.80M | -1.02B |
Balance Sheet | |||||
Total Assets | 17.51B | 17.18B | 16.41B | 12.33B | 14.75B |
Cash, Cash Equivalents and Short-Term Investments | 3.96B | 4.11B | 4.66B | 3.12B | 3.77B |
Total Debt | 2.68B | 2.75B | 4.12B | 5.43B | 4.21B |
Total Liabilities | 10.47B | 9.56B | 10.76B | 7.68B | 9.78B |
Stockholders Equity | 7.04B | 7.61B | 5.64B | 4.65B | 4.97B |
Cash Flow | |||||
Free Cash Flow | 1.86B | 766.00M | 1.98B | -2.74B | 910.50M |
Operating Cash Flow | 3.42B | 3.16B | 3.89B | -2.45B | 2.11B |
Investing Cash Flow | -1.43B | -1.56B | -1.90B | 937.10M | -918.10M |
Financing Cash Flow | -2.00B | -1.33B | -1.05B | 1.62B | -297.40M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
82 Outperform | $31.06B | 14.69 | 27.12% | 1.36% | 10.61% | 37.32% | |
80 Outperform | $27.38B | 8.47 | 27.70% | ― | 4.23% | 13.13% | |
76 Outperform | $33.40B | 7.42 | 30.07% | 1.25% | 3.01% | -0.90% | |
73 Outperform | $11.54B | 24.74 | 47.69% | 5.06% | 7.45% | -13.53% | |
64 Neutral | $10.64B | 16.52 | 6.24% | 2.15% | 3.01% | -28.89% | |
59 Neutral | $7.28B | 14.18 | -21.27% | ― | 1.50% | ― | |
49 Neutral | $16.24B | 46.51 | 4.30% | 2.42% | 1.64% | 284.24% |